Neoepitope immunoassay: An assay for human interleukin 1β based on an antibody induced conformational change

Journal of Immunoassay

Volumn 17, Issue 4, 1996, Pages 353-369

  Towbin, Harry ^a   Erard, François ^a   Van Oostrum, Jan ^a   Schmitz, Albert ^a   Rordorf, Christiane ^a  

^a CIBA GEIGY LTD   (Switzerland)

Author keywords

antigen antibody complex; chemiluminescence; conformation; epitope mapping; immunization; interleukin 1

Indexed keywords

INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; MONOCLONAL ANTIBODY;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CHEMOLUMINESCENCE; CONFORMATIONAL TRANSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; IMMUNIZATION; NONHUMAN; PROTEIN CONFORMATION;

EID: 0029806641     PISSN: 01971522     EISSN: None     Source Type: Journal    
DOI: 10.1080/01971529608005798     Document Type: Article

References (16)

1. Wilson, I.A. and Stanfield, R.L. Antibody-antigen interactions: new structures and new conformational changes. Curr. Opin. Struct. Biol. 1994; 4: 857-67.
2. Hoenig, J., Rordorf-Adam, C., Siegmund, C., Wiedemann, W., and Erard, F. Increased interleukin-1beta (IL-1beta) concentration in gingival tissue from periodontitis patients. J. Periodontal Res. 1989; 24: 326-67.
3. Grütter, M.G., van Oostrum, J., Priestle, J.P., et al. A mutational analysis of receptor binding sites of interleukin 1beta: differences in binding of human interleukin-1beta muteins to human and mouse receptors. Protein Eng. 1994; 7: 663-71.
4. Stocker, J.W., Forster, H.K., Miggiano, V., Stähli, C., Staiger, G., Takacs, B., and Staehelin, T. Generation of two new mouse myeloma cell lines 'PAI' and 'PAI-O' for hybridoma production. Hoffmann-LaRoche Research Disclosure 1982; 21713: 155-7.
5. Köhler, G. and Milstein, C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256: 495-7.
6. Galfrè, G., Howe, ,S.C., Milstein, C., Butcher, G.W., and Howard, J.C. Antibodies to major histocompatibility antigens produced by hybrid lines. Nature 1977; 266: 550-1.
7. Parham, P. On the fragmentation of monoclonal IgG1, IgG2a, and IgG2b from BALB/c mice. J. Immunol. 1983; 131: 2895-902.
8. Joss, U. and Towbin, H. Acridinium ester labelled cytokines: Receptor binding studies with human interleukin-1alpha, interleukin-1beta and interferon-gamma. J. Biolumin. Chemilumin. 1994; 9: 21-8.
9. Law, S.-J., Miller, T., Piran, U., Klukas, C., Chang, S., and Unger, J. Novel poly-substituted aryl acridinium esters and their use in immunoassay. J. Biolumin. Chemilumin. 1989; 4: 88-98
10. Henning, D. and Nielsen, K. Peroxidase-labelled monoclonal antibodies for use in enzyme immunoassay. J. Immunoassay 1987; 8: 297-307.
11. Orencole, S.F. and Dinarello, C.A. Characterization of a subclone (D10S) of the D10.G4.1 helper T-cell line which proliferates to attomolar concentrations of interleukin-1 in absence of mitogens. Cytokine 1989; 1: 14-22.
12. Geiger, T., Towbin, H., Cosenti-Vargas, A., et al. Neutralization of interleukin-1 beta in vivo with a monoclonal antibody alleviates collagen-induced arthritis in DBA/1 mice and prevents the associated acute-phase response. Clin. Exp. Rheumatol. 1993; 11: 515-22.
13. Weidner, K.M., Denzin, L.K., and Voss, E.W.,Jr. Molecular stabilization effects of interactions between anti-metatype antibodies and liganded antibody. J. Biol. Chem. 1992; 267: 10281-8.
14. Towbin, H., Motz, J., Oroszlan, P., and Zingel, O. Sandwich immunoassay for the hapten angiotensin II. A novel assay principle based on antibodies against immune complexes. J. Immunol. Methods 1995; 181: 167-76.
15. Bouige, P., Iscaki, S., and Pillot, J. Immune complexes as immunizing agents to increase the number of monoclonal antibody producing hybrids and to deviate the response to poorly immunogenic epitopes. Hybridoma 1990; 9: 519-25.
16. Songsakphisarn, R. and Goldstein, N. The use of a novel immune complex to isolate neutralizing antibodies to basic fibroblast growth factor. Hybridoma 1993; 12: 343-9.